Rafael Amado

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Bruce Blefeld, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rafael Amado:

Company Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. EVP of R&D Stock Option (Right to Buy) 368,589 $3,545,826 $9.62 23 Mar 2022 Direct
Allogene Therapeutics, Inc. EVP of R&D Common Stock 541,946 $1,720,353 $3.17 07 Oct 2022 Direct
Zai Lab Ltd President, Head of Global Oncology Research and Development American Depositary Shares 52,391 $913,279 $17.43 31 Dec 2025 Direct
Zai Lab Ltd President, Head of Global Oncology Research and Development Restricted Share Units 42,000 $387,009 $35.89 30 Dec 2025 Direct
Poseida Therapeutics, Inc. Director Common Stock 0 $0 $9.60 08 Jan 2025 Direct
Zai Lab Ltd President, Head of Global Oncology Research and Development Stock Options (Right to Buy) 65,523 12 Mar 2025 Direct
Poseida Therapeutics, Inc. Director Stock Option (Right to Buy) 0 08 Jan 2025 Direct

Insider Reports Filed by Rafael Amado

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZLAB Zai Lab Ltd 30 Dec 2025 3 -$188,039 4 President, Head of Global Oncology Research and Development 02 Jan 2026, 16:15
ZLAB Zai Lab Ltd 08 Aug 2025 1 -$105,000 4 President, Head of Global Oncology Research and Development 12 Aug 2025, 16:45
ZLAB Zai Lab Ltd 03 Apr 2025 3 -$100,284 4 President, Head of Global Oncology Research and Development 07 Apr 2025, 16:48
ZLAB Zai Lab Ltd 01 Apr 2025 3 -$270,677 4 President, Head of Global Oncology Research and Development 03 Apr 2025, 17:06
ZLAB Zai Lab Ltd 17 Mar 2025 1 -$115,230 4 President, Head of Global Oncology Research and Development 19 Mar 2025, 16:41
ZLAB Zai Lab Ltd 12 Mar 2025 2 $0 4 President, Head of Global Oncology Research and Development 14 Mar 2025, 17:14
/report/000141588925001090-amado-rafael-2025-01-08 Poseida Therapeutics, Inc. 08 Jan 2025 3 $0 4 Director 08 Jan 2025, 14:17
ZLAB Zai Lab Ltd 30 Dec 2024 3 -$199,289 4 President, Head of Global Oncology Research and Development 02 Jan 2025, 16:13
ZLAB Zai Lab Ltd 12 Aug 2024 1 -$50,463 4 President, Head of Global Oncology Research and Development 14 Aug 2024, 16:18
/report/000095017024074862-amado-rafael-2024-06-17 Poseida Therapeutics, Inc. 17 Jun 2024 2 $0 4 Director 18 Jun 2024, 16:12
ZLAB Zai Lab Ltd 03 Apr 2024 3 +$55,123 4 President, Head of Global Oncology Research and Development 05 Apr 2024, 17:47
ZLAB Zai Lab Ltd 01 Apr 2024 2 $0 4 President, Head of Global Oncology Research and Development 03 Apr 2024, 21:43
ZLAB Zai Lab Ltd 15 Mar 2024 1 -$47,980 4 President, Head of Global Oncology Research and Development 19 Mar 2024, 16:12
ZLAB Zai Lab Ltd 29 Dec 2023 5 -$509,169 4 President, Head of Global Oncology Research and Development 03 Jan 2024, 19:26
/report/000120919123026474-amado-rafael-2023-05-01 Poseida Therapeutics, Inc. 01 May 2023 2 $0 4 Director 02 May 2023, 16:14
/report/000120919123024365-amado-rafael-2023-04-13 Poseida Therapeutics, Inc. 13 Apr 2023 0 $0 3 Director 14 Apr 2023, 17:23
ZLAB Zai Lab Ltd 03 Apr 2023 2 $0 4 President, Head of Global Oncology Research and Development 05 Apr 2023, 16:05
ZLAB Zai Lab Ltd 30 Dec 2022 2 $0 4 President, Head of Global Oncology Research and Development 03 Jan 2023, 15:10
ZLAB Zai Lab Ltd 30 Dec 2022 0 $0 3 President, Head of Global Oncology Research and Development Exhibit List: Exhibit 24 - Power of Attorney 03 Jan 2023, 15:05
ALLO Allogene Therapeutics, Inc. 07 Oct 2022 2 -$100,099 4 EVP of R&D 11 Oct 2022, 16:35
ALLO Allogene Therapeutics, Inc. 03 Oct 2022 1 -$99,201 4 EVP of R&D 05 Oct 2022, 16:02
ALLO Allogene Therapeutics, Inc. 02 Aug 2022 1 -$23,940 4 EVP of R&D and CMO 02 Aug 2022, 17:40
ALLO Allogene Therapeutics, Inc. 05 Jul 2022 1 -$22,880 4 EVP of R&D and CMO 06 Jul 2022, 16:16
ALLO Allogene Therapeutics, Inc. 21 Jun 2022 1 -$22,360 4 EVP of R&D and CMO 22 Jun 2022, 16:47
ALLO Allogene Therapeutics, Inc. 19 May 2022 1 -$85,092 4 EVP of R&D and CMO 19 May 2022, 17:40
ALLO Allogene Therapeutics, Inc. 23 Mar 2022 2 $0 4 EVP of R&D and CMO 25 Mar 2022, 17:52
ALLO Allogene Therapeutics, Inc. 15 Mar 2022 1 -$39,848 4 EVP of R&D and CMO 17 Mar 2022, 17:59
ALLO Allogene Therapeutics, Inc. 01 Oct 2021 1 -$280,185 4 EVP of R&D and CMO 04 Oct 2021, 17:55
ALLO Allogene Therapeutics, Inc. 18 May 2021 1 $0 4 EVP of R&D and CMO 20 May 2021, 17:22